XTL Biopharmaceuticals Stock (NASDAQ: XTLB) stock price, news, charts, stock research, profile.
Open | $2.640 |
Close | $2.810 |
Volume / Avg. | 234.329K / 804.590K |
Day Range | 2.560 - 2.830 |
52 Wk Range | 0.750 - 4.990 |
Market Cap | $14.821M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of XTL Biopharmaceuticals (NASDAQ: XTLB) through any online brokerage.
Other companies in XTL Biopharmaceuticals’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for XTL Biopharmaceuticals (NASDAQ: XTLB) was reported by HC Wainwright & Co. on Friday, May 8, 2015. The analyst firm set a price target for 6.00 expecting XTLB to rise to within 12 months (a possible 120.59% upside). 0 analyst firms have reported ratings in the last year.
The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $2.72 last updated March 28, 2024 at 7:47 PM EDT.
There are no upcoming dividends for XTL Biopharmaceuticals.
XTL Biopharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for XTL Biopharmaceuticals.
XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.